Propriedades Psicométricas da Versão Brasileira do Questionário de Percepção da Doença Revisado para Mulheres Saudáveis (IPQ-RH)

Correspondence address: Rebeca Veras de Andrade Vieira. Universidade do Vale do Rio dos Sinos. Avenida UNISINOS, 950, São Leopoldo-RS, Brazil. CEP 93.022-000. E-mail: rebecavieirapsico@gmail.com

Rebeca Veras de Andrade Vieira is a Postdoctoral fellow (PNPD- CAPES) in Psychology at Universidade do Vale do Rio dos Sinos, São Leopoldo-RS, Brazil.

Juliana Burges Sbicigo is a Postdoctoral in Psychology at Universidade Federal do Rio Grande do Sul, Porto Alegre-RS, Brazil

Maria Julia Armiliato is a Master’s candidate for the Psychology Graduate Program at Universidade do Vale do Rio dos Sinos, São Leopoldo-RS, Brazil.

Elisa Kern de Castro is an Associate Professor of the Universidade Lusíada de Lisboa, Portugal.

Maria João Figueiras is an Associate Professor at Zayed University, College of Natural and Health Sciences, Psychology Department, Abu Dhabi, United Arab Emirates.

Authors’ Contribution:

All authors made substantial contributions to the conception and design of this study, to data analysis and interpretation, and the manuscript revision and approval of the final version. All the authors assume public responsibility for the content of the manuscript.

Associate editor:

Luciana Mourão Cerqueira e Silva

Dimension	Item	M (SD)	Factor loadings
Timeline Acute/Chronic	Breast cancer lasts a short time	3.52 (1.01)	.372
	Breast cancer is a more permanent than temporary illness	3.47 (1.00)	.484
	Breast cancer lasts a long time	3.26 (1.00)	.657
	Breast cancer passes quickly	3.72 (.87)	.436
	I think breast cancer lasts for the rest of the life	2.43 (1.11)	.377
Consequences	Breast cancer is a serious condition	4.53 (.62)	.258
	Breast cancer seriously affects the way the patient sees himself/herself as an individual	4.26 (.68)	.301
	Breast cancer causes serious financial consequences	3.98 (.82)	.620
	Breast cancer causes difficulties for those who are close to the patient	4.09 (.78)	.644
Personal Control	What the patient does can determine whether breast cancer improves or worsens	3.93 (.84)	.380
	The evolution of breast cancer depends on the patient himself/herself	3.80 (.92)	.604
	The patient has the power to influence the evolution of breast cancer	3.70 (.95)	.626
Treatment Control	Treatment is effective in curing breast cancer	3.90 (.96)	.389
	The negative effects of breast cancer can be prevented or avoided by treatment	3.93 (.69)	.572
	Breast cancer treatment can control the illness	4.10 (.57)	.230
Coherence	Symptoms of breast cancer confuse me	3.60 (1.00)	.523
	Breast cancer is a mystery to me	3.01 (1.19)	.772
	I do not understand breast cancer	3.06 (1.16)	.765
Timeline Cyclical	Symptoms of breast cancer come and go in cycles	3.18 (.97)	.504
	Breast cancer is very unpredictable	3.84 (.84)	.564
	Breast cancer goes through phases in which it improves or worsens	3.65 (.86)	.654
Emotional Representation	I get depressed when I think about breast cancer	3.39 (1.27)	.849
	When I think about breast cancer, I get disturbed	3.08 (1.28)	.850
	If I had breast cancer, I would feel angry	2.90 (1.23)	.509
	I get anxious when I think about breast cancer	3.17 (1.23)	.770
	Breast cancer makes me feel scared	3.65 (1.24)	.666

Dimension	Item	M (SD)	Factor loadings
Psychological Attributions	Stress and worry	3.62 (1.06)	.573
	Emotional state	3.55 (1.06)	.631
	Personality	2.69 (1.08)	.625
	Personal attitudes	3.46 (1.11)	.617
	Family problems	3.12 (1.16)	.728
	Overwork	2.57 (1.08)	.538
General Risk Factors	Heredity	4.18 (.81)	.218
	Overweight	3.04 (1.12)	.476
	Diet	3.46 (1.07)	.634
	Pollution	2.97 (1.09)	.536
	Poor medical care in the past	3.89 (.88)	.358
	Ageing	2.64 (1.05)	.326
	Immunity	3.91 (.81)	.329

Factors	M (SD)	Min-Max	1	2	3	4	5	6	7	8	9
1. T_A/C	16.40(3.10)	6-25	1
2. C	16.86(1.94)	11-20	.16**	1
3. PC	11.42(1.95)	3-15	-.08	.15**	1
4. TC	11.93(1.47)	7-15	-.16**	.18**	.27**	1
5. CO	9.66(2.69)	3-15	.02	.15**	.01	.13*	1
6. TC	10.66(1.93)	4-15	.03	.09	.14**	.10	.35**	1
7. ER	16.18(4.93)	5-25	.04	.14**	-.15**	.04	.48**	.28**	1
8. PA	19.00(4.58)	6-30	.05	.17**	-.13*	.06	.32**	.18**	.68**	1
9. GRF	24.09(3.71)	15-35	-.06	.03	-.03	.01	.13*	.03	.41**	.50**	1

	Elementary School (ES)			High School (HS)			Higher Education (HS)			H of Kruskal-Wallis	EF vs. EM	EF vs. ES		EM vs. ES
	(n = 109)			(n = 151)			(n = 55)			chi-2 (p)	Z ^a	Z ^a		Z ^a
	M (DP)	Md	Q1-Q3	M (DP)	Md	Q1-Q3	M (DP)	Md	Q1-Q3
1. T_A/C	16.34 (2.92)	17	14-18	16.18 (3.14)	16	14-18	17.14 (3.28)	18	15-19	3.31	^b	^b		^b
2. C	16.66 (1.72)	17	16-17	16.95 (2.09)	17	16-19	17.01 (1.95)	17	16-19	1.64	^b	^b		^b
3. PC	11.34 (1.63)	12	10-12	11.64 (1.91)	12	10-13	11.00 (2.61)	12	10-12	4.20	^b	^b		^b
4. TC	12.12 (1.23)	12	12-13	11.96 (1.48)	12	11-13	11.43 (1.84)	12	10-12	9.77**	12.01	44.15**		2.14
5. CO	10.53 (2.21)	11	8-12	9.46 (2.79)	9	8-12	8.34 (2.71)	8	6-10	27.35**	36.13**	76.13**		40.00**
6. TC	10.98 (1.80)	11	10-12	10.68 (1.94)	11	10-12	9.89 (2.05)	10	9-12	12.28**	13.89	51.35**		37.46**
7. ER	17.66 (4.66)	18	14-21	15.31 (4.99)	16	12-19	15.30 (4.81)	14	11-19	16.55**	43.21**	45.10**		1.90
8. PA	17.80 (4.44)	18	14-21	19.15 (4.69)	20	16-22	18.90 (4.76)	19	16-22	5.69	b	b		b
9. FGR	23.76 (3.30)	24	22-26	24.50 (3.96)	24	22-28	23.50 (3.73)	24	21-26	3.50	b	b		b
	Self-Examination Never/Rarely (n = 167)			Self-Examination Weekly/Monthly (n = 122)			U of Mann-Whitney (p)	No Family History (n = 226)			With Family History (n = 94)			U of Mann-Whitney (p)
	*M (DP)*	Md	*Q1-Q3*	*Md (DP)*	Md	*Q1-Q3*		*M (SD)*	Md	*Q1-Q3*	*M (SD)*	Md	*Q1-Q3*
1. T_A/C	16.25 (2.99)	16	14-18	16.41 (3.22)	17	14-18	9675.50	16.53 (3.09)	17	16-18	16.10 (3.13)	16	14-18	9632.00
2. C	16.68 (1.88)	17	16-18	17.19 (1.93)	17	16-19	8737.00*	16.74 (1.94)	17	16-18	17.15 (1.96)	17	16-19	9584.00
3. PC	11.20 (1.77)	12	10-12	11.66 (2.14)	12	11-13	8486.50*	11.43 (1.86)	12	12-13	11.42 (2.19)	12	10-12	10586.00
4. TC	11.76 (1.42)	12	11-12	12.16 (1.51)	12	12-13	8746.50*	12.06 (1.42)	12	8-12	11.61 (1.56)	12	11-12	8754.59*
5. CO	9.94 (2.49)	10	8-12	9.45 (2.82)	10	7-12	9046.00	9.92 (2.60)	10	10-12	9.01 (2.80)	9	6-12	8540.50*
6. TC	10.64 (1.89)	11	10-12	10.66 (1.93)	11	10-12	10039.00	10.83 (1.85)	11	10-12	10.26 (2.09)	10	9-12	9101.00*
7. ER	16.94 (4.74)	18	14-20	15.69 (5.00)	16	11-20	8651.50*	16.04 (5.01)	17	12-20	16.51 (4.80)	17	12-20	10093.50
8. PA	18.58 (4.32)	18	15-22	18.66 (5.16)	18	16-22	10129.00	18.53 (4.63)	18	15-22	18.87 (4.80)	19	16-22	10058.00
9. GRF	24.23 (3.49)	24	22-26	24.18 (4.04)	24	21-27	10001.50	23.93 (3.52)	24	22-16	24.46 (1.14)	24	22-28	10045.50

[1] Correspondence address: Rebeca Veras de Andrade Vieira. Universidade do Vale do Rio dos Sinos. Avenida UNISINOS, 950, São Leopoldo-RS, Brazil. CEP 93.022-000. E-mail: rebecavieirapsico@gmail.com

Brasil

Brasil

Propriedades Psicométricas da Versão Brasileira do Questionário de Percepção da Doença Revisado para Mulheres Saudáveis (IPQ-RH)

Resumo